Early Detection of Acute Myeloid Leukemia (AML) Using YOLOv12 Deep Learning Model

arXiv cs.CV / 4/20/2026

📰 NewsIdeas & Deep AnalysisModels & Research

Key Points

  • The study proposes a deep learning approach to classify acute myeloid leukemia (AML) cells across multiple categories despite visual similarity among cell types.
  • It uses the YOLOv12 model with two segmentation strategies that rely on cell- and nucleus-based features, preceded by image preprocessing using Hue-channel processing and Otsu thresholding.
  • The researchers found that YOLOv12 combined with Otsu thresholding on cell-based segmentation performed best, achieving 99.3% accuracy on both validation and test sets.
  • The work aims to improve the accuracy of AML visual classification, potentially supporting earlier and more reliable detection workflows.

Abstract

Acute Myeloid Leukemia (AML) is one of the most life-threatening type of blood cancers, and its accurate classification is considered and remains a challenging task due to the visual similarity between various cell types. This study addresses the classification of the multiclasses of AML cells Utilizing YOLOv12 deep learning model. We applied two segmentation approaches based on cell and nucleus features, using Hue channel and Otsu thresholding techniques to preprocess the images prior to classification. Our experiments demonstrate that YOLOv12 with Otsu thresholding on cell-based segmentation achieved the highest level of validation and test accuracy, both reaching 99.3%.